PETTE HEINRICH INST has a total of 37 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OXFORD BIOMEDICA LTD, FATE THERAPEUTICS INC and BUNDESREPUBLIK DEUTSCHLAND LET.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 6 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Australia | 1 | |
#8 | Brazil | 1 | |
#9 | Czechia | 1 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | Hungary | 1 | |
#12 | Japan | 1 | |
#13 | Norway | 1 | |
#14 | Poland | 1 | |
#15 | Slovakia | 1 | |
#16 | Ukraine | 1 | |
#17 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Heterocyclic compounds | |
#7 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Von Laer Meike-Dorothee | 11 |
#2 | Hauber Joachim | 8 |
#3 | Baum Christopher | 6 |
#4 | Laer Meike-Dorothee Von | 6 |
#5 | Schaumann Daniel | 5 |
#6 | Beyer Winfried | 4 |
#7 | Hildinger Markus | 3 |
#8 | Hauber Ilona | 3 |
#9 | Schaefer Wilhelm | 2 |
#10 | Kloeckner Jessica | 2 |
Publication | Filing date | Title |
---|---|---|
DE102012103405A1 | New disubstituted heteroaryl compound useful for treating a disease consisting of viral diseases, proliferative diseases, neurodegenerative diseases, diabetes, malaria, and HIV infection | |
WO2012104059A2 | Lentiviral vector comprising at least two tar elements | |
CN103154256A | Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains | |
EP2036556A1 | Piperidone derivatives and medical uses thereof | |
EP1834669A1 | Use of specific hydrazone compounds for the treatment of viral infections | |
DE102006011486A1 | Use of new substances for pathogen defense and growth promotion in crops | |
US6589763B1 | Retroviral hybrid vectors pseudotyped with LCMV | |
DE10045016A1 | Retroviral vectors with foreign sequence insertion between the retroviral primer binding site and the retroviral splice donor | |
DE19957838A1 | Gene therapy of HIV-infected people through expression of membrane-anchored gp41 peptides | |
DE19856463A1 | Retroviral LCMV pseudotyped hybrid vectors | |
DE19822115A1 | Retroviral gene transfer vectors |